Published in J Virol on October 08, 2008
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature (2004) 17.56
Virus entry into animal cells. Adv Virus Res (1989) 7.78
pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A (1980) 5.21
Adsorptive endocytosis of Semliki Forest virus. J Mol Biol (1980) 4.94
Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. J Cell Biol (1980) 3.47
Western equine encephalitis virus is a recombinant virus. Proc Natl Acad Sci U S A (1988) 3.19
The clathrin endocytic pathway in viral infection. EMBO J (1998) 2.74
Quantitation of flaviviruses by fluorescent focus assay. J Virol Methods (2006) 2.25
The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol (2006) 2.22
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med (2005) 1.93
Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein. J Virol (1991) 1.80
Antibody-directed targeting of retroviral vectors via cell surface antigens. J Virol (2001) 1.50
Biological weapons--a primer for microbiologists. Annu Rev Microbiol (2001) 1.38
Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of scid mice. J Virol (1993) 1.28
In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol (2002) 1.16
Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. J Virol (2005) 1.09
Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. J Virol (2005) 1.04
Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J Virol (2001) 1.02
Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus. J Virol (2004) 1.02
Directed mutagenesis of a Sindbis virus pathogenesis site. Virology (1993) 1.00
Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies. Hum Gene Ther (2005) 0.93
Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions. Mol Ther (2005) 0.83
Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis (2012) 5.31
Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med (2015) 5.16
Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol (2010) 3.18
Dimorphic effects of Notch signaling in bone homeostasis. Nat Med (2008) 2.82
West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis (2003) 2.27
Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One (2009) 2.22
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Proc Natl Acad Sci U S A (2006) 2.07
The history and evolution of human dengue emergence. Adv Virus Res (2008) 2.05
Arbovirus evolution in vivo is constrained by host alternation. Proc Natl Acad Sci U S A (2008) 2.04
Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog (2011) 1.95
Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein. Proc Natl Acad Sci U S A (2004) 1.95
Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol (2011) 1.86
Chimeric alphavirus vaccine candidates for chikungunya. Vaccine (2008) 1.78
4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J (2011) 1.77
Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg Infect Dis (2004) 1.73
Negevirus: a proposed new taxon of insect-specific viruses with wide geographic distribution. J Virol (2012) 1.67
Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J Virol (2007) 1.64
Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog (2011) 1.62
Introductions of West Nile virus strains to Mexico. Emerg Infect Dis (2006) 1.61
Molecular epidemiology of group C viruses (Bunyaviridae, Orthobunyavirus) isolated in the Americas. J Virol (2005) 1.60
Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine (2007) 1.58
Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol (2011) 1.57
Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proc Natl Acad Sci U S A (2011) 1.57
Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells. J Virol (2005) 1.57
Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum Mol Genet (2009) 1.56
Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells. PLoS Pathog (2009) 1.56
Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J Virol (2003) 1.54
Evolutionary processes among sylvatic dengue type 2 viruses. J Virol (2007) 1.54
Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol (2005) 1.53
Direct broad-range detection of alphaviruses in mosquito extracts. Virology (2007) 1.52
Transmission of a Venezuelan equine encephalitis complex Alphavirus by Culex (Melanoconion) gnomatos (Diptera: Culicidae) in northeastern Peru. J Med Entomol (2005) 1.52
Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad. Virology (2009) 1.51
Dengue emergence and adaptation to peridomestic mosquitoes. Emerg Infect Dis (2004) 1.50
Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg Infect Dis (2008) 1.49
Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology (2006) 1.49
Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus. J Virol (2002) 1.49
Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis (2004) 1.47
Evolutionary patterns of eastern equine encephalitis virus in North versus South America suggest ecological differences and taxonomic revision. J Virol (2009) 1.45
Evaluation of methods to assess transmission potential of Venezuelan equine encephalitis virus by mosquitoes and estimation of mosquito saliva titers. Am J Trop Med Hyg (2005) 1.44
Venezuelan equine encephalitis virus in the mosquito vector Aedes taeniorhynchus: infection initiated by a small number of susceptible epithelial cells and a population bottleneck. Virology (2007) 1.39
Endemic eastern equine encephalitis in the Amazon region of Peru. Am J Trop Med Hyg (2007) 1.38
Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence. J Virol (2008) 1.36
Potential role of sylvatic and domestic African mosquito species in dengue emergence. Am J Trop Med Hyg (2005) 1.36
Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J Virol (2007) 1.35
Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. J Virol (2002) 1.33
Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission. Am J Trop Med Hyg (2006) 1.33
Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol (2012) 1.31
Landscape ecology of sylvatic chikungunya virus and mosquito vectors in southeastern Senegal. PLoS Negl Trop Dis (2012) 1.28
Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. J Virol (2006) 1.26
Characterization of a novel Negevirus and a novel Bunyavirus isolated from Culex (Culex) declarator mosquitoes in Trinidad. J Gen Virol (2013) 1.26
Serologic evidence of arboviral infections among humans in Kenya. Am J Trop Med Hyg (2011) 1.23
Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication. Proc Natl Acad Sci U S A (2012) 1.20
IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells. Virology (2008) 1.20
A proposal to change existing virus species names to non-Latinized binomials. Arch Virol (2010) 1.18
Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling. Vaccine (2011) 1.17
Vector-borne transmission imposes a severe bottleneck on an RNA virus population. PLoS Pathog (2012) 1.16
The hamster as an animal model for eastern equine encephalitis--and its use in studies of virus entrance into the brain. J Infect Dis (2004) 1.16
Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology (2007) 1.16
Zika Virus: Diagnosis, Therapeutics, and Vaccine. ACS Infect Dis (2016) 1.15
Identification of dengue fever cases in Houston, Texas, with evidence of autochthonous transmission between 2003 and 2005. Vector Borne Zoonotic Dis (2013) 1.14
Venezuelan equine encephalitis virus transmission and effect on pathogenesis. Emerg Infect Dis (2006) 1.14
Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus. J Virol (2005) 1.13
Short report: serological evidence of West Nile virus activity in El Salvador. Am J Trop Med Hyg (2005) 1.13
Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella. Future Virol (2011) 1.12
Rodent models for HIV-1 infection and disease. Curr HIV Res (2003) 1.12
Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J Clin Microbiol (2004) 1.11
Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol (2013) 1.11
Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol (2008) 1.10
Yellow fever virus maintenance in Trinidad and its dispersal throughout the Americas. J Virol (2010) 1.09
Characterization and detection of artificial replication-competent lentivirus of altered host range. Mol Ther (2003) 1.09
Venezuelan equine encephalitis in Panama: fatal endemic disease and genetic diversity of etiologic viral strains. PLoS Negl Trop Dis (2009) 1.07
Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny. J Interferon Cytokine Res (2005) 1.07
Eastern equine encephalitis in Latin America. N Engl J Med (2013) 1.05
Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia. Emerg Infect Dis (2003) 1.05
Chikungunya virus 3' untranslated region: adaptation to mosquitoes and a population bottleneck as major evolutionary forces. PLoS Pathog (2013) 1.04
Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. J Virol (2005) 1.04
Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains. Virology (2008) 1.04
Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine. Vaccine (2012) 1.03
Vaccines for Venezuelan equine encephalitis. Vaccine (2009) 1.03
Venezuelan equine encephalitis virus, southern Mexico. Emerg Infect Dis (2004) 1.03
Structure of the recombinant alphavirus Western equine encephalitis virus revealed by cryoelectron microscopy. J Virol (2010) 1.03
Western Equine Encephalitis submergence: lack of evidence for a decline in virus virulence. Virology (2008) 1.01
Antigenic relationships between sylvatic and endemic dengue viruses. Am J Trop Med Hyg (2008) 1.01
Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response. J Virol (2011) 1.01
Experimental Everglades virus infection of cotton rats (Sigmodon hispidus). Emerg Infect Dis (2004) 1.00
Experimental infection of Aedes sollicitans and Aedes taeniorhynchus with two chimeric Sindbis/Eastern equine encephalitis virus vaccine candidates. Am J Trop Med Hyg (2008) 1.00
Deforestation alters phytotelm habitat availability and mosquito production in the Peruvian Amazon. Ecol Appl (2006) 0.99
Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol (2013) 0.99
Susceptibility of Ochlerotatus taeniorhynchus (Diptera: Culicidae) to infection with epizootic (subtype IC) and enzootic (subtype ID) Venezuelan equine encephalitis viruses: evidence for epizootic strain adaptation. J Med Entomol (2004) 0.99
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model. Vaccine (2013) 0.99
IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice. Virology (2013) 0.99
A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation. Vaccine (2012) 0.98
Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion. J Virol (2005) 0.98
Venezuelan equine encephalitis virus infection of spiny rats. Emerg Infect Dis (2005) 0.98
Urban epidemic of dengue virus serotype 3 infection, Senegal, 2009. Emerg Infect Dis (2014) 0.97
Larval ecology of mosquitoes in sylvatic arbovirus foci in southeastern Senegal. Parasit Vectors (2012) 0.96
Emergence of Congenital Zika Syndrome: Viewpoint From the Front Lines. Ann Intern Med (2016) 0.96
Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics. Emerg Infect Dis (2003) 0.96